Roche Holdings, Inc / Spark Therapeutics, Inc merger inquiry
UK — Competition & Markets Authority (CMA) · 2020-02-10 · UK · verified record
Themes: Consumer protection · Online marketplaces · Online platforms · Search services
Ecosystems: UK Digital Markets (DMCCA)
The CMA investigated and cleared the anticipated acquisition by Roche Holdings, Inc. of Spark Therapeutics, Inc.
1 Anticipated acquisition by Roche Holdings, Inc. of Spark Therapeutics, Inc. Decision on relevant merger situation and substantial lessening of competition ME/6831/19 The CMA’s decision on reference under section 33(1) of the Enterprise Act 2002 given on 16 December 2019. Full text of the decision
Sign in to read this record in the app with full provenance, themes and related developments — free, 20 searches a day, no card needed.
Read in Vellum Search → Official source ↗Source content © UK — Competition & Markets Authority (CMA) — served per the publisher's reuse terms. Vellum metadata & summary © Vellum AI Group Ltd. Reuse & rights.